Continuation of therapeutic dose heparin for critically ill patients with COVID-19

Intensive Care Med. 2023 Jul;49(7):873-875. doi: 10.1007/s00134-023-07095-8. Epub 2023 May 31.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticoagulants / therapeutic use
  • COVID-19*
  • Critical Illness / therapy
  • Heparin* / therapeutic use
  • Heparin, Low-Molecular-Weight
  • Humans
  • SARS-CoV-2

Substances

  • Heparin
  • Anticoagulants
  • Heparin, Low-Molecular-Weight